| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1246819-61-3 | Demethyl Naproxen Sulfate | C13H12O6S |
| 1246819-63-5 | 8-Methoxy Psoralen-13C,D3 | C1113CH5D3O4 |
| 1246819-64-6 | Levamisole-d5 Hydrochloride | C11H8D5ClN2S |
| 1246819-65-7 | 1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine | C18H21N3O4 |
| 1246819-68-0 | 1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine-d4 | C18H17D4N3O4 |
| 1246819-71-5 | N,N-Di-n-butyl-N-3-[4-nitrobenzoyloxy)propyl]ammonium Chloride | C18H29ClN2O4 |
| 1246819-73-7 | 2-Acetyl-1-pyrroline-13C2 | C413C2H9NO |
| 1246819-76-0 | 6-Methyl-3-(trifluoromethyl)pivalanilide | C13H16F3NO |
| 1246819-78-2 | (1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-carboxylate | C11H10ClN5O2 |
| 1246819-79-3 | Midazolam-d6 bromide | C18H7D6ClFN3 |
| 1246819-85-1 | Nor Propranolol | C13H9D7ClNO2 |
| 1246819-87-3 | Plerixafor | C28H50D4N8 |
| 1246819-95-3 | N-(2,2,2-Trichloroethoxy)carbonyl] Bisnor-(cis)-tilidine | C18H20Cl3NO4 |
| 1246820-00-7 | (3R)-3-(Benzoylamino)-4-oxo-pentanoic Acid Methyl Ester | C13H15NO4 |
| 1246820-03-0 | Benzydamine-d6 N-Oxide | C19H17D6N3O2 |
| 1246820-04-1 | Hypoxanthine-13C2,15N | C313C2H4N315NO |
| 1246820-05-2 | 8-Bromo-3-butyl-1-chloro-5,10-dihydroimidazo[1,5-b]isoquinoline | C15H16BrClN2 |
| 1246820-08-5 | 4-Methyl-2-nitroaniline-d6 | C7H2D6N2O2 |
| 1246820-09-6 | Methylenedioxy Pyrovalerone-d8 Hydrochloride | C16H14D8ClNO3 |
| 1246820-13-2 | rac-trans 3’-Thiomethyl Nicotine Dihydrochloride | C11H18Cl2N2S |
| 1246820-19-8 | Loxapine-d8 Hydrochloride | C18H11D8Cl2N3O |
| 1246820-20-1 | Medetomidine-d3 Hydrochloride | C13H14D3ClN2 |
| 1246820-22-3 | N-Methyl-d3-o-phenylenediamine | C7H7D3N2 |
| 1246820-23-4 | N-Methylguanidine-d3 Hydrochloride | C2H5D3ClN3 |
| 1246820-26-7 | rac 1-O-Trimethylsilyl 3-Chloro-1,2-propanediol | C6H15ClO2Si |
| 1246820-28-9 | (S)-N-[2-[6-Allyloxy-5-bromo-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide | C16H20BrNO2 |
| 1246820-29-0 | (S)-N-[2-[7-Allyl-5-bromo-6-benzyloxy-2,3-dihydro-1H-inden-1-yl]ethyl]propanamide | C24H28BrNO2 |
| 1246820-30-3 | 1-Acetyl-2-[1-(2-naphthyl)ethyl]benzene | C20H18O |
| 1246820-32-5 | (S)-N-[6-Benzyloxy-5-bromo-7-(2-hydroxyethyl)-2,3-dihydro-1H-inden-1-ylidene)ethyl]propanamide | C23H28BrNO3 |
| 1246820-34-7 | 1-(tert-Butyldimethylsilyloxy)-1-(2’-trimethylsilyl)ethynyl-cyclopropane-d4 | C14H24D4OSi2 |
| 1246820-40-5 | 10,20-Di-O-methoxymethyl SN-38 | C26H28N2O7 |
| 1246820-44-9 | Aminoiminomethanesulfonic Acid-15N2,13C | 13CH415N2O3S |
| 1246820-46-1 | N-Boc-N-desethyl Acetildenafil | C28H38N6O5 |
| 1246820-49-4 | Candesartan tert-Butyl Ester | C28H28N6O3 |
| 1246820-50-7 | Carbutamide-d9 | C11H8D9N3O3S |
| 1246820-51-8 | 1,3-Cyclohexanedione-13C6 | 13C6H8O2 |
| 1246820-54-1 | N-Desmethyl Asenapine-d4 Hydrochloride | C16H11D4Cl2NO |
| 1246820-55-2 | 2-Despiperidyl-2-amino Repaglinide Methyl Ester | C23H30N2O4 |
| 1246820-58-5 | 2H-2-Ethyl-d5 Candesartan | C26H19D5N6O3 |
| 1246820-62-1 | Losartan-d4 Carboxylic Acid | C22H17D4ClN6O2 |
| 1246820-66-5 | Mosapride-d5 | C21H20D5ClFN3O3 |
| 1246820-70-1 | Tetra-O-acetyl Iopromide | C26H32I3N3O12 |
| 1246820-72-3 | N-(2,2,2-Trichloroethoxy)carbonyl] Nortilidine-d3 | C19H19D3Cl3NO4 |
| 1246820-73-4 | 6,7,8,9-Tetrahydro Carvedilol | C24H30N2O4 |
| 1246820-77-8 | 2,5-Pyridinedicarboxylic Acid-d3 | C7H2D3NO4 |
| 1246820-84-7 | N-(2,2,2-Trichloroethoxy)carbonyl] Nortilidine | C19H22Cl3NO4 |
| 1246820-92-7 | Propyl-d7 Paraben | C10H5D7O3 |
| 1246829-05-9 | (2,3-Dimethylpyridin-4-yl)boronic Acid | C7H10BNO2 |
| 1246832-84-7 | N-Boc-N-desethyl Sunitinib-d5 | C25H26D5FN4O4 |
| 1246832-91-6 | (E/Z)-Chlorprothixene-d6 Hydrochloride | C18H13D6Cl2NS |